|premium|

Mid-afternoon market update: Dow jumps over 100 points; Cooper Tire (CTB Stock) shares jump

Toward the end of trading Monday, the Dow traded up 0.40% to 31,621.04 while the NASDAQ fell 1.57% to 13,656.22. The S&P also fell, dropping 0.28% to 3,895.94.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 28,134,270 cases with around 498,900 deaths. India confirmed a total of at least 11,005,850 confirmed cases and 156,380 deaths, while Brazil reported over 10,168,170 COVID-19 cases with 246,500 deaths. In total, there were at least 111,415,030 cases of COVID-19 worldwide with over 2,467,200 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares rose 4.4% on Monday. Meanwhile, top gainers in the sector included GasLog Ltd. GLOG 19.64%, up 20%, and SM Energy Company SM 20.95%, up 22%.

In trading on Monday, utilities shares fell by 2.4%.

Top Headline

DISH Network Corporation DISH 3.39% reported better-than-expected earnings for its fourth quarter.

DISH reported quarterly earnings of $1.24 per share, beating analysts’ estimates of $0.75 per share. The company’s quarterly sales came in at $4.56 billion, versus expectations of $4.42 billion.

Equities Trading UP

Rodgers Silicon Valley Acquisition Corp. RSVA 36.83% shares shot up 40% to $22.08. Enovix will go public through a merger with Rodgers Silicon Valley Acquisition Corp.

Shares of Celsion Corporation CLSN 51.32% got a boost, shooting 68% to $3.1989 after the company received FDA Fast Track designation for GEN-1 in advanced ovarian cancer.

Cooper Tire & Rubber Company CTB 30.41% shares were also up, gaining 30% to $56.97 after the company announced it will be acquired by Goodyear around $2.8 billion. Cooper Tire & Rubber also reported Q4 results.

Check out these big movers of the day

Equities Trading DOWN

Otonomy, Inc. OTIC 42.49% shares tumbled 42% to $3.11 after the company announced that its Phase 3 clinical trials of OTIVIDEX in patients with Meniere's disease did not meet its primary endpoint.

Shares of Ebix, Inc. EBIX 40.42% were down 40% to $30.30 after the company reaffirmed business forecast for FY 2021.

Brainstorm Cell Therapeutics Inc. BCLI 33.19% was down, falling 33% to $4.64 after the company announced the FDA concluded from their initial review that the current level of NurOwn clinical data does not provide the threshold of substantial evidence that FDA is seeking to support a biologics license application.

Commodities

In commodity news, oil traded up 4.1% to $61.69, while gold traded up 1.7% to $1,807.80.

Silver traded up 3.3% Monday to $28.165 while copper rose 1.8% to $4.1465.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 0.44%, the Spanish Ibex Index fell 0.48% and the German DAX 30 declined 0.31%. Meanwhile, the French CAC 40 fell 0.11%, London’s FTSE 100 fell 0.18% and Italy’s FTSE MIB fell 0.55%.

German Ifo Business Climate indicator increased to 92.4 in February from a revised reading of 90.3 in the earlier month.

Economics

The Chicago Fed National Activity Index rose to 0.66 in January versus a revised reading of 0.41 in December.

The index of leading economic indicators rose 0.5% for January.

The Dallas Fed manufacturing index rose 10.2 points to a reading of 17.2 in February .

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD remains offered below 1.1600, seems vulnerable near multi-month low

The EUR/USD pair struggles to capitalize on the overnight bounce from the 1.1530 region, or the lowest level since November 2025, and lower for the third consecutive day on Wednesday. Spot prices slide back below the 1.1600 mark during the Asian session and seem vulnerable to slide further.

GBP/USD slips below key averages as geopolitical risks mount

GBP/USD fell about 0.35% on Tuesday, settling around 1.3350 after slipping below the 200-day Exponential Moving Average for the first time since early December. The pair has pulled back sharply from its late-January high near 1.3870, shedding over 500 pips in a series of lower highs and lower lows. 

Gold rebounds ahead of US ADP, will it last?

Gold finds renewed Asian bids and retests $5,230 early Wednesday after the heavy sell-off on Tuesday. The US Dollar stands tall amid escalating Middle East tensions and reduced dovish Fed expectations. Gold defends $5,000 or 50% Fibo level after facing rejection at the 78.6% Fibo resistance at $5,342 amid bullish RSI.  

Bitcoin, Ethereum and Ripple struggle for direction as consolidation persists

Bitcoin, Ethereum and Ripple prices trade with a cautious tone at the time of writing on Wednesday as upside momentum continues to fade across the broader crypto market. BTC remains within a parallel channel, ETH struggles below key resistance, while XRP remains fragile within a descending channel. These top three cryptocurrencies by market capitalization continue to struggle to establish a directional bias amid the consolidation phase.

Energy shock 2.0: Why rising Gas prices could hit the Euro

Even without a confirmed, sustained disruption, the mere risk to a key global energy chokepoint is enough to inject a significant premium into European Gas markets. And for the Euro, that matters.

Ripple falters amid sell-off jitters and negative funding rates

Ripple (XRP) has come under pressure, drifting lower to $1.35 at the time of writing on Tuesday. The over 2% correction looks poised to erase the previous day’s gains, which lifted the remittance token to $1.42.